Optimum inhibition of MCF-7 breast cancer cells by efficient targeting of the macropinocytosis using optimized paclitaxel-loaded nanoparticles
Authors:
- Bahgat FayedBFBahgat Fayed
- Jayalakshmi JagalJJJayalakshmi Jagal
- Manju N. JayakumarManju N. Jayakumar
- Zainab M. Al ShareefZSZainab M. Al Shareef
- Suleiman I. SharifSSSuleiman I. Sharif
- Ayman NoreddinANAyman Noreddin
- Mohammad H. SemreenMSMohammad H. Semreen
- Hany A. OmarHOHany A. Omar
- Mohamed HaiderMohamed Haider
- Sameh S.M. SolimanSSSameh S.M. Soliman
- 2 July 2022
- journal article
- research article
- Published by Elsevier in Life Sciences
- Vol. 305, 120778
Abstract
No abstract availableKeywords
Funding Information
- University of Sharjah (2101110147)
This publication has 33 references indexed in Scilit:
- MCF-7 Cells--Changing the Course of Breast Cancer Research and Care for 45 YearsJNCI: Journal of the National Cancer Institute, 2015
- Macropinosome quantitation assayMethodsX, 2014
- Nanoparticle-directed sub-cellular localization of doxorubicin and the sensitization breast cancer cells by circumventing GST-Mediated drug resistanceBiomaterials, 2014
- Endocytic Uptake and Intracellular Trafficking of Bis-MPA-Based Hyperbranched Copolymer Micelles in Breast Cancer CellsBiomacromolecules, 2012
- Local clustering of transferrin receptors promotes clathrin-coated pit initiationJournal of Cell Biology, 2010
- Cancer Chemotherapy: An Annotated HistoryJournal of Veterinary Internal Medicine, 2010
- Phosphatidylinositol-3-OH Kinase or RAS Pathway Mutations in Human Breast Cancer Cell LinesMolecular Cancer Research, 2007
- Targeting of nanoparticles to the clathrin-mediated endocytic pathwayBiochemical and Biophysical Research Communications, 2007
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001
- Phase II Trial of Taxol, an Active Drug in the Treatment of Metastatic Breast CancerJNCI: Journal of the National Cancer Institute, 1991